Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Morgan

Showing results (171-180 of 191) with videos related to

Pageof 20
Sort By:
Gene Therapy|July 1, 1997
Selection and use of ligands for receptor-mediated gene delivery to myogenic cellsW G Feero, S Li, J D Rosenblatt, et al.
Scientific Reports|June 7, 2022
Quantifying biomarkers of axonal degeneration in early glaucoma to find the disc at riskR L Bartlett, B E Frost, K E Mortlock, et al.
The American Journal of Medicine|January 1, 1989
Immunologic assessment of a cluster of asymptomatic HTLV-I-infected individuals in New OrleansR D deShazo, N Chadha, J E Morgan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2000
Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouseC J Mann, K Honeyman, A J Cheng, et al.
Developmental Biology|April 1, 1994
Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell linesJ E Morgan, J R Beauchamp, C N Pagel, et al.
Infection and Immunity|March 16, 2011
In vivo regulation of the Vi antigen in Salmonella and induction of immune responses with an in vivo-inducible promoterCarole Janis, Andrew J Grant, Trevelyan J McKinley, et al.
Human Gene Therapy|May 8, 2001
A new immunodeficient mouse model for human myoblast transplantationR N Cooper, A Irintchev, J P Di Santo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2010
Intracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirusNeil J Bennett, Omodele Ashiru, Fiona J E Morgan, et al.
The Journal of Antimicrobial Chemotherapy|November 29, 2013
Prevalence and characterization of human mecC methicillin-resistant Staphylococcus aureus isolates in EnglandG K Paterson, F J E Morgan, E M Harrison, et al.
Human Gene Therapy|September 5, 2007
Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscleV Arechavala-Gomeza, I R Graham, L J Popplewell, et al.
Pageof 20

Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Gene Therapy|July 1, 1997
Selection and use of ligands for receptor-mediated gene delivery to myogenic cellsW G Feero, S Li, J D Rosenblatt, et al.
Scientific Reports|June 7, 2022
Quantifying biomarkers of axonal degeneration in early glaucoma to find the disc at riskR L Bartlett, B E Frost, K E Mortlock, et al.
The American Journal of Medicine|January 1, 1989
Immunologic assessment of a cluster of asymptomatic HTLV-I-infected individuals in New OrleansR D deShazo, N Chadha, J E Morgan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2000
Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouseC J Mann, K Honeyman, A J Cheng, et al.
Developmental Biology|April 1, 1994
Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell linesJ E Morgan, J R Beauchamp, C N Pagel, et al.
Infection and Immunity|March 16, 2011
In vivo regulation of the Vi antigen in Salmonella and induction of immune responses with an in vivo-inducible promoterCarole Janis, Andrew J Grant, Trevelyan J McKinley, et al.
Human Gene Therapy|May 8, 2001
A new immunodeficient mouse model for human myoblast transplantationR N Cooper, A Irintchev, J P Di Santo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2010
Intracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirusNeil J Bennett, Omodele Ashiru, Fiona J E Morgan, et al.
The Journal of Antimicrobial Chemotherapy|November 29, 2013
Prevalence and characterization of human mecC methicillin-resistant Staphylococcus aureus isolates in EnglandG K Paterson, F J E Morgan, E M Harrison, et al.
Human Gene Therapy|September 5, 2007
Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscleV Arechavala-Gomeza, I R Graham, L J Popplewell, et al.
Pageof 20